DE1950858A1 - Verfahren zur Konzeptionsverhuetung - Google Patents
Verfahren zur KonzeptionsverhuetungInfo
- Publication number
- DE1950858A1 DE1950858A1 DE19691950858 DE1950858A DE1950858A1 DE 1950858 A1 DE1950858 A1 DE 1950858A1 DE 19691950858 DE19691950858 DE 19691950858 DE 1950858 A DE1950858 A DE 1950858A DE 1950858 A1 DE1950858 A1 DE 1950858A1
- Authority
- DE
- Germany
- Prior art keywords
- dose
- menstrual cycle
- administered
- acetate
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 10
- 230000027758 ovulation cycle Effects 0.000 claims description 8
- 239000000583 progesterone congener Substances 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 4
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- -1 methyl chlormadinone acetate Chemical compound 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19691950858 DE1950858A1 (de) | 1969-10-09 | 1969-10-09 | Verfahren zur Konzeptionsverhuetung |
| FR7031344A FR2081321A1 (enrdf_load_stackoverflow) | 1969-10-09 | 1970-08-27 | |
| GB1289873D GB1289873A (enrdf_load_stackoverflow) | 1969-10-09 | 1970-09-07 | |
| ZA706105A ZA706105B (en) | 1969-10-09 | 1970-09-08 | Contraceptive method and agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19691950858 DE1950858A1 (de) | 1969-10-09 | 1969-10-09 | Verfahren zur Konzeptionsverhuetung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1950858A1 true DE1950858A1 (de) | 1971-05-06 |
Family
ID=5747704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19691950858 Pending DE1950858A1 (de) | 1969-10-09 | 1969-10-09 | Verfahren zur Konzeptionsverhuetung |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE1950858A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2081321A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1289873A (enrdf_load_stackoverflow) |
| ZA (1) | ZA706105B (enrdf_load_stackoverflow) |
-
1969
- 1969-10-09 DE DE19691950858 patent/DE1950858A1/de active Pending
-
1970
- 1970-08-27 FR FR7031344A patent/FR2081321A1/fr not_active Withdrawn
- 1970-09-07 GB GB1289873D patent/GB1289873A/en not_active Expired
- 1970-09-08 ZA ZA706105A patent/ZA706105B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2081321A1 (enrdf_load_stackoverflow) | 1971-12-03 |
| GB1289873A (enrdf_load_stackoverflow) | 1972-09-20 |
| ZA706105B (en) | 1971-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4344405C2 (de) | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption | |
| DE3229612A1 (de) | Pharmazeutische packung | |
| EP0628312B1 (de) | Kombinationspräparat zur Kontrazeption | |
| DE3213248A1 (de) | Pharmazeutische packung zur behandlung von symptomen der menopause bei frauen | |
| EP1310257A2 (de) | Kombination zur hormonalen Kontrazeption | |
| DE19549264A1 (de) | Verfahren und Kit zur Kontrazeption | |
| DE3836862A1 (de) | Mittel zur transdermalen applikation von steroidhormonen | |
| DE3238984C2 (enrdf_load_stackoverflow) | ||
| DE3504933C2 (de) | Arzneimittel zur Behandlung von Diabetes und Leberfunktionsstörungen | |
| DE1950858A1 (de) | Verfahren zur Konzeptionsverhuetung | |
| Verzár et al. | The action of thyrotrophic hormone and cortisone on the uptake of 131I by the thyroid gland | |
| Jokipii et al. | Comparison of four dosage schedules in the treatment of giardiasis with metronidazole | |
| DE2325070A1 (de) | Pharmazeutische zubereitungen zur prophylaxe und zur behandlung von kapillarvenoesen erkrankungen | |
| DE2434849A1 (de) | Herzstaerkende dosierungseinheit mit einer ein praeparat enthaltenden kapsel | |
| DD299619A5 (de) | Verwendung einer zusammensetzung zur verhinderung von prostatakrebs | |
| DE3535396A1 (de) | Kontrazeptive zusammensetzung | |
| DE3416374C2 (enrdf_load_stackoverflow) | ||
| Robson et al. | The Role of Amines in Placental Function: 5-Hydroxytryptamine, Placental Function and Toxæmia of Pregnancy | |
| DE3003036A1 (de) | Mittel zur verhinderung und beseitigung von glatzen | |
| EP0214924B1 (de) | Oxytocin und Antigestagen zur Einleitung der Geburt | |
| KHALIL et al. | The treatment of aplastic anaemia with anabolic steroids | |
| Harding | Oral substitution therapy with ethinyl estradiol and alpha–estradiol | |
| DE1950857A1 (de) | Antikonzeptionsmittel | |
| DE1617837A1 (de) | Methode zur Kontrazeptien | |
| OGAWA et al. | STUDIES ON THE THYROID UPTAKE OF I131 I. EFFECT OF PITUITARY HORMONES |